Why Cytoreductive Surgery Requires Real Selection
Cytoreductive surgery is considered for selected patients with peritoneal surface disease where aggressive tumour clearance, sometimes combined with HIPEC, may offer a meaningful option.
The decision is never based on one scan alone.
What usually matters most:
- Tumour biology and pathology
- Disease distribution and estimated burden
- Prior operations and prior systemic treatment
- Performance status and nutritional reserve
- Whether meaningful cytoreduction appears realistically achievable
What the Review Typically Includes
For international patients, the value lies in reviewing feasibility before travel.
Typical review components:
- Operative history and discharge reports
- Pathology review and tumour type clarification
- Cross-sectional imaging assessment
- Discussion of expected ICU need, hospital stay, and recovery intensity
- Honest judgement on whether CRS, HIPEC, or another route is more realistic
Why Coordination Is Critical
These are the cases where poor coordination wastes the most time, energy, and money.
BB Global Health helps collect the full file package so the surgical team can review feasibility in advance, reduce unnecessary travel, and set expectations more clearly for patients and families.
That makes the decision process calmer, more transparent, and better grounded in the actual disease picture.